CytoDyn Announces Collaboration with Dr. Bruce Torbett, The Scripps Research Institute, to study PRO 140 in a Pre-exposure Prophylaxis (PrEP) Model of HIV Infection

Feb 26, 2013 11:29am EST

CytoDyn Announces Investor Update Conference Call on Friday, February 22

Feb 19, 2013 9:00am EST

CytoDyn to Attend 31st Annual J.P. Morgan Healthcare Conference

Jan 07, 2013 7:51am EST

CytoDyn Appoints Former Ambassador to Bahrain as Middle East Business Consultant

Jan 02, 2013 8:52am EST

CytoDyn Elects Two New Directors and Appoints New Chief Financial Officer

Dec 18, 2012 9:17am EST

CytoDyn Expands Outreach Through Increased Online Presence

Dec 07, 2012 2:54pm EST

CytoDyn Announces Phase IIB Clinical Trial Agreement with Dr. Jeffrey Jacobson, Drexel University College of Medicine

Nov 16, 2012 1:41pm EST

CytoDyn to Present Findings on its Feline Immunodeficiency Virus (FIV) Therapeutic Antibody Program

Oct 05, 2012 8:45am EDT

CytoDyn Retains Gibraltar Associates for Corporate and Investor Communications

Oct 03, 2012 10:02am EDT

CytoDyn Inc. Names Dr. Nader Pourhassan New CEO; Announces New Chief Scientific Officer

Sep 11, 2012 5:52pm EDT